Stock Comparison
MRNA vs REGN
Moderna Inc and Regeneron Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$26.69B
$66.35B
P/E (TTM)
—
15.5
Forward P/E
23.0
14.1
Price/Sales
12.0
4.5
Price/Book
3.2
2.1
EV/EBITDA
4.6
10.5
Dividend Yield
—
0.58%
Profitability
Net Margin
-143.50%
29.60%
Operating Margin
-131.10%
20.70%
Return on Equity
-36.60%
14.50%
Return on Assets
-13.10%
6.13%
Growth (YoY)
Revenue Growth
260.20%
19.00%
Earnings Growth
-85.10%
-7.20%
Price & Risk
Beta
1.0
0.2
52-Week High
$69.28
$818.90
52-Week Low
$22.28
$516.07
Analyst Target
$43.45
$833.31
Compare MRNA and REGN your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.